National Agency for Medicines and Medical Devices
The National Agency for Medicines and Medical Devices (NAMMD) is a public institution established in Romania by Government Decision No. 734 of 21 July 2010. Its mission is to protect and promote public health by evaluating documentation for authorization, monitoring the safety of medicinal products for therapeutic use, ensuring access to accurate information, maintaining high performance and safety of medical devices, assessing medical-technical units, issuing technical procedures, and ensuring institutional administrative effectiveness.
The NAMMD aims to strengthen its status as a reference national authority and a reliable source of accurate information. Its strategic objectives include protecting public health, providing clear and timely information, contributing to the projection of future legal frameworks, and coordinating a quality and qualified workforce to cope with future challenges.
Class I, IIa, IIb and III
The manufacturer or the authorized representative of the manufacturer, based in Romania, has the obligation to register with the NAMMDR in accordance with the provisions of Article 6 of Order of the Minister of Health no. 3539 of 2022 on approval of the Methodological Rules regarding the introduction of medical devices on the market and the registration of economic operators into the European database on medical devices (EUDAMED), as well as into the national database and exemption from the procedures for assessment of compliance, when placing the following types of medical devices on the market:
Form F1 – Notification form for the introduction of medical devices on the market
The registration process takes about 4-6 weeks after submission for Class I devices. For the other classes, it depends on the contract with the notified body and the type of device.
No Fees
5 Years
The information provided by the manufacturer together with the medical device must be in the Romanian language
The medical devices vigilance system is a system for reporting and evaluating incidents and field safety corrective actions (FSCA). This system is primarily aimed at the health and safety of patients, users, and others by reducing the likelihood of an incident occurring again at another location.
This is done by evaluating reported incidents and, where appropriate, disseminating information which could be used to prevent the recurrence or mitigate the consequences of such incidents.
According to the requirements set out in Articles 13 and 14 of the MDR, if an importer or a distributor based in Romania considers or has reason to believe that a device is exposed to a serious risk or is a counterfeit device, it must inform the NAMMDR about this. If the device in question is also available in other EU member states, the distributor or importer must inform the competent authorities in the affected markets about the potentially serious risk or about the counterfeit device.
Field safety corrective action is a corrective action taken by a manufacturer, for technical or medical reasons, to prevent or reduce the risk of an incident occurring in relation to a medical device made available on the market. Field Safety Corrective Actions are brought to the attention of the Competent Authorities via the Field Safety Corrective Action (FSCA) form.
Field safety corrective actions may consist of changes to the medical device, recommendations provided by the manufacturer regarding the use of the device and/or tracking of patients, users, etc. or returning a medical device to suppliers. Manufacturers bring field safety corrective actions to the attention of operators/users through Field Safety Notifications (FSN).
On 5 April 2017, 2 new Regulations on medical devices were adopted, and they entered into force on 25 May 2017. These replace the existing Directives. The new rules will only apply after a transitional period. Namely, 3 years after entry into force for the Regulation on medical devices (spring 2020) and 5 years after entry into force (spring 2022) for the Regulation on in vitro diagnostic medical devices.
On market placement of the following types of medical devices, NAMMD registration of manufacturers, or their authorized representatives established in Romania, is mandatory: Class I medical devices, including sterile and / or measuring devices; Custom-made medical devices and custom-made active implantable medical devices; Systems and procedure packages & In-vitro diagnostic medical devices.
In Romania, NAMMD notification by manufacturers, their authorized representative, importers, or distributors established in Romania/other Member State is mandatory when placing into service the following types of medical devices:
Before placing a medical device into the market.
Contact us for free consultation: info@omcmedical.co.uk
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
Our team will be happy to respond your queries. Contact us directly with your questions or for scheduling FREE consultation and we’ll be in touch as soon as possible.
To launch a medical device in a country, medical devices must comply with the local country’s regulatory requirements. Let us be your trusted partner in bringing your medical devices to the Global market. Contact us today to learn more about how we can assist you in every step of the way.
This will close in 0 seconds